BDBM50336182 4-(4-{[3-Carbamoyl-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazol-8-yl]carbamoyl}-5-chloropyridin-2-yl)-1-[(1-methyl-1H-pyrazol-4-yl)methyl]piperazine-2-carboxylicacid::CHEMBL1669570
SMILES: Cn1cc(CN2CCN(CC2C(O)=O)c2cc(C(=O)Nc3ccc4CCc5c(nn(c5-c4c3)-c3ccc(F)cc3)C(N)=O)c(Cl)cn2)cn1
InChI Key: InChIKey=YZGWZCOIRRVTDL-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inhibitor of nuclear factor kappa-B kinase subunit beta (Homo sapiens (Human)) | BDBM50336182 (4-(4-{[3-Carbamoyl-1-(4-fluorophenyl)-4,5-dihydro-...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 3.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. Curated by ChEMBL | Assay Description Inhibition of human recombinant IKK2 in human PBMC | Bioorg Med Chem 19: 1242-55 (2011) Article DOI: 10.1016/j.bmc.2010.12.027 BindingDB Entry DOI: 10.7270/Q2F76CTN | |||||||||||
More data for this Ligand-Target Pair |